Yuhan Corporation (000105.KS)

KRW 101900.0

(-3.04%)

Total Debt Summary of Yuhan Corporation

  • Yuhan Corporation's latest annual total debt in 2023 was 230.07 Billion KRW , up 141.24% from previous year.
  • Yuhan Corporation's latest quarterly total debt in 2024 Q1 was 291.26 Billion KRW , down 0.0% from previous quarter.
  • Yuhan Corporation reported annual total debt of 95.36 Billion KRW in 2022, down -23.56% from previous year.
  • Yuhan Corporation reported annual total debt of 124.76 Billion KRW in 2021, up 1.36% from previous year.
  • Yuhan Corporation reported quarterly total debt of 291.26 Billion KRW for 2024 Q1, down 0.0% from previous quarter.
  • Yuhan Corporation reported quarterly total debt of - KRW for 2023 Q4, down -100.0% from previous quarter.

Annual Total Debt Chart of Yuhan Corporation (2023 - 2007)

Historical Annual Total Debt of Yuhan Corporation (2023 - 2007)

Year Total Debt Total Debt Growth
2023 230.07 Billion KRW 141.24%
2022 95.36 Billion KRW -23.56%
2021 124.76 Billion KRW 1.36%
2020 123.08 Billion KRW 34.56%
2019 91.47 Billion KRW -22.86%
2018 118.58 Billion KRW -11.39%
2017 133.82 Billion KRW -31.93%
2016 196.6 Billion KRW 29.68%
2015 151.6 Billion KRW 115.95%
2014 70.2 Billion KRW 34.74%
2013 52.1 Billion KRW 543.21%
2012 8.1 Billion KRW -10.99%
2011 9.1 Billion KRW 0.0%
2010 9.1 Billion KRW -21.28%
2009 11.56 Billion KRW -8.4%
2008 12.62 Billion KRW -76.47%
2007 53.63 Billion KRW 0.0%

Peer Total Debt Comparison of Yuhan Corporation

Name Total Debt Total Debt Difference
Yuyu Pharma, Inc. 39.4 Billion KRW -483.831%
Dong-A Socio Holdings Co., Ltd. 691.88 Billion KRW 66.747%
Ildong Holdings Co., Ltd. 382.06 Billion KRW 39.781%
HANDOK Inc. 300.01 Billion KRW 23.312%
Kukje Pharma Co., Ltd. 30.66 Billion KRW -650.345%
Dong-A ST Co., Ltd. 406.7 Billion KRW 43.43%
SAMSUNG PHARM. Co., LTD. 595.48 Million KRW -38535.915%
Hanmi Pharm. Co., Ltd. 572.86 Billion KRW 59.839%
Hanall Biopharma Co.,Ltd 1.29 Billion KRW -17727.669%
Ilyang Pharmaceutical Co.,Ltd 85.15 Billion KRW -170.164%
Dong Sung Bio Pharm.Co.,Ltd. 43.27 Billion KRW -431.676%
MYUNGMOON Pharm co.,Ltd 90.48 Billion KRW -154.273%
Hana Pharm Co., Ltd. 26.53 Billion KRW -767.112%
Yuyu Pharma, Inc. 39.4 Billion KRW -483.831%
Ilsung Pharmaceuticals Co., Ltd. 238.12 Million KRW -96517.493%
REYON Pharmaceutical Co., Ltd. 225.05 Billion KRW -2.23%
Aprogen pharmaceuticals,Inc. 180.99 Billion KRW -27.113%
JW Holdings Corporation 554.58 Billion KRW 58.515%
Ildong Pharmaceutical Co., Ltd. 217.84 Billion KRW -5.614%
Chong Kun Dang Pharmaceutical Corp. 219.76 Billion KRW -4.69%
JW Pharmaceutical Corporation 170.28 Billion KRW -35.113%
Shin Poong Pharm.Co.,Ltd. 46.15 Billion KRW -398.514%
Hyundai Pharmaceutical Co., Ltd. 39.2 Billion KRW -486.843%
Samil Pharmaceutical Co.,Ltd 175.87 Billion KRW -30.812%
Jeil Pharmaceutical Co.,Ltd 84.96 Billion KRW -170.782%
Yuyu Pharma, Inc. 39.4 Billion KRW -483.831%
Kwang Dong Pharmaceutical Co., Ltd. 235.64 Billion KRW 2.364%
Daewoong pharmaceutical Co.,Ltd 469.68 Billion KRW 51.016%
JW Pharmaceutical Corporation 170.28 Billion KRW -35.113%
Yuhan Corporation 230.07 Billion KRW 0.0%
Jeil Pharma Holdings Inc 173.03 Billion KRW -32.966%
Yungjin Pharm. Co., Ltd. 66.88 Billion KRW -243.996%
Suheung Co., Ltd. 467.85 Billion KRW 50.824%
JW Pharmaceutical Corporation 170.28 Billion KRW -35.113%
Samjin Pharmaceuticals Co., Ltd. 118.63 Billion KRW -93.927%
Korea United Pharm Inc. 40.33 Billion KRW -470.344%
CKD Bio Corp. 146.92 Billion KRW -56.589%
Daewon Pharmaceutical Co., Ltd. 146.04 Billion KRW -57.53%
Dongwha Pharm.Co.,Ltd 48.25 Billion KRW -376.779%
Whan In Pharm Co.,Ltd. 632.02 Million KRW -36302.228%
Shin Poong Pharm.Co.,Ltd. 46.15 Billion KRW -398.514%
Chong Kun Dang Holdings Corp. 468.03 Billion KRW 50.843%
Boryung Corporation 204.21 Billion KRW -12.661%
Bukwang Pharmaceutical Co., Ltd. 79.38 Billion KRW -189.81%
Ilyang Pharmaceutical Co.,Ltd 85.15 Billion KRW -170.164%
JW Lifescience Corporation 46.31 Billion KRW -396.777%